UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:FGFR2-CCAR2 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: FGFR2-CCAR2 | FusionPDB ID: 30280 | FusionGDB2.0 ID: 30290 | Hgene | Tgene | Gene symbol | FGFR2 | CCAR2 | Gene ID | 2263 | 57805 |
Gene name | fibroblast growth factor receptor 2 | cell cycle and apoptosis regulator 2 | |
Synonyms | BBDS|BEK|BFR-1|CD332|CEK3|CFD1|ECT1|JWS|K-SAM|KGFR|TK14|TK25 | DBC-1|DBC1|KIAA1967|NET35|p30 DBC|p30DBC | |
Cytomap | 10q26.13 | 8p21.3 | |
Type of gene | protein-coding | protein-coding | |
Description | fibroblast growth factor receptor 2BEK fibroblast growth factor receptorbacteria-expressed kinasekeratinocyte growth factor receptorprotein tyrosine kinase, receptor like 14 | cell cycle and apoptosis regulator protein 2cell division cycle and apoptosis regulator protein 2deleted in breast cancer 1p30 DBC protein | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | P21802 | Q8N163 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000346997, ENST00000351936, ENST00000356226, ENST00000357555, ENST00000358487, ENST00000360144, ENST00000369056, ENST00000369059, ENST00000369060, ENST00000369061, ENST00000457416, ENST00000478859, ENST00000359354, ENST00000490349, | ENST00000520861, ENST00000521301, ENST00000308511, ENST00000389279, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 24 X 20 X 12=5760 | 2 X 2 X 2=8 |
# samples | 38 | 2 | |
** MAII score | log2(38/5760*10)=-3.92199748799873 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: FGFR2 [Title/Abstract] AND CCAR2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | CCAR2(22462355)-FGFR2(123239535), # samples:2 FGFR2(123243212)-CCAR2(22464120), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. FGFR2-CCAR2 seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | FGFR2 | GO:0008284 | positive regulation of cell proliferation | 8663044 |
Hgene | FGFR2 | GO:0008543 | fibroblast growth factor receptor signaling pathway | 8663044|15629145 |
Hgene | FGFR2 | GO:0018108 | peptidyl-tyrosine phosphorylation | 15629145|16844695 |
Hgene | FGFR2 | GO:0046777 | protein autophosphorylation | 15629145 |
Tgene | CCAR2 | GO:0031647 | regulation of protein stability | 23398316 |
Tgene | CCAR2 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 23398316 |
Tgene | CCAR2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process | 15824730 |
Tgene | CCAR2 | GO:0045892 | negative regulation of transcription, DNA-templated | 20160719 |
Tgene | CCAR2 | GO:0090311 | regulation of protein deacetylation | 21030595 |
Fusion gene breakpoints across FGFR2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CCAR2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | LUSC | TCGA-66-2765-01A | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + |
ChimerDB4 | LUSC | TCGA-66-2765 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000369061 | FGFR2 | chr10 | 123243212 | - | ENST00000308511 | CCAR2 | chr8 | 22464120 | + | 6569 | 2115 | 48 | 4736 | 1562 |
ENST00000369061 | FGFR2 | chr10 | 123243212 | - | ENST00000389279 | CCAR2 | chr8 | 22464120 | + | 5526 | 2115 | 48 | 4736 | 1562 |
ENST00000357555 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2450 | 2353 | 217 | 2448 | 744 |
ENST00000358487 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2671 | 2574 | 171 | 2669 | 832 |
ENST00000356226 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2694 | 2597 | 545 | 2692 | 715 |
ENST00000369060 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2537 | 2440 | 385 | 2535 | 717 |
ENST00000369059 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2697 | 2600 | 539 | 2695 | 718 |
ENST00000346997 | FGFR2 | chr10 | 123243212 | - | ENST00000308511 | CCAR2 | chr8 | 22464120 | + | 6761 | 2307 | 12 | 4928 | 1638 |
ENST00000346997 | FGFR2 | chr10 | 123243212 | - | ENST00000389279 | CCAR2 | chr8 | 22464120 | + | 5718 | 2307 | 12 | 4928 | 1638 |
ENST00000457416 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2993 | 2896 | 490 | 2991 | 834 |
ENST00000351936 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 3039 | 2942 | 545 | 3037 | 830 |
ENST00000360144 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2755 | 2658 | 519 | 2753 | 744 |
ENST00000369056 | FGFR2 | chr10 | 123243212 | - | ENST00000308511 | CCAR2 | chr8 | 22464120 | + | 6782 | 2328 | 24 | 4949 | 1641 |
ENST00000369056 | FGFR2 | chr10 | 123243212 | - | ENST00000389279 | CCAR2 | chr8 | 22464120 | + | 5739 | 2328 | 24 | 4949 | 1641 |
ENST00000478859 | FGFR2 | chr10 | 123243212 | - | ENST00000521301 | CCAR2 | chr8 | 22464120 | + | 2429 | 2332 | 715 | 2427 | 571 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000369061 | ENST00000308511 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001134714 | 0.99886537 |
ENST00000369061 | ENST00000389279 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001499821 | 0.9985002 |
ENST00000357555 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.002964345 | 0.9970356 |
ENST00000358487 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001452469 | 0.9985475 |
ENST00000356226 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.002505796 | 0.9974942 |
ENST00000369060 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.002088799 | 0.99791116 |
ENST00000369059 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.002598987 | 0.997401 |
ENST00000346997 | ENST00000308511 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.000862366 | 0.99913764 |
ENST00000346997 | ENST00000389279 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001094242 | 0.9989058 |
ENST00000457416 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001538768 | 0.99846125 |
ENST00000351936 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001344383 | 0.99865556 |
ENST00000360144 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.002846029 | 0.997154 |
ENST00000369056 | ENST00000308511 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.000910875 | 0.9990891 |
ENST00000369056 | ENST00000389279 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.001165219 | 0.9988348 |
ENST00000478859 | ENST00000521301 | FGFR2 | chr10 | 123243212 | - | CCAR2 | chr8 | 22464120 | + | 0.002485415 | 0.9975146 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >30280_30280_1_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000346997_CCAR2_chr8_22464120_ENST00000308511_length(amino acids)=1638AA_BP=765 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGE YLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCP AGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVV GGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVL PAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVSAESSSSMNSNTPLVRITTRLS STADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGIVTSLHDYFGVVDEEVFFQLSVVKGRLPQLGEKVL VKAAYNPGQAVPWNAVKVQTLSNQPLLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSHTLHLSHLNRFPARG PHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDFLELQRRYRSLLVPSDFLSVHLSWLSAFPLSQPFSL HHPSRIQVSSEKEAAPDAGAEPITADSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLGRKEEEAVLVGGEWS PSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQTVVVYLPDVWTIMPTLEEWEALCQQKAAEAAPPTQ EAQGETEPTEQAPDALEQAADTSRRNAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKERISFEVMVLAELFL EMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKDEAQNEGPATESEAPLKEDGLLPKPLSSGGEEEEKP RGEASEDLCEMALDPELLLLRDDGEEEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVFFDANWCGYLHRRDL ERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNLDLLPPPGKSTKPGAAPTEHKALVSHNGSLINVGSL LQRAEQQDSGRLYLENKIHTLELKLEESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQELRRRLTPLQLEIQR -------------------------------------------------------------- >30280_30280_2_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000346997_CCAR2_chr8_22464120_ENST00000389279_length(amino acids)=1638AA_BP=765 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGE YLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCP AGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVV GGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVL PAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVSAESSSSMNSNTPLVRITTRLS STADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGIVTSLHDYFGVVDEEVFFQLSVVKGRLPQLGEKVL VKAAYNPGQAVPWNAVKVQTLSNQPLLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSHTLHLSHLNRFPARG PHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDFLELQRRYRSLLVPSDFLSVHLSWLSAFPLSQPFSL HHPSRIQVSSEKEAAPDAGAEPITADSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLGRKEEEAVLVGGEWS PSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQTVVVYLPDVWTIMPTLEEWEALCQQKAAEAAPPTQ EAQGETEPTEQAPDALEQAADTSRRNAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKERISFEVMVLAELFL EMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKDEAQNEGPATESEAPLKEDGLLPKPLSSGGEEEEKP RGEASEDLCEMALDPELLLLRDDGEEEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVFFDANWCGYLHRRDL ERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNLDLLPPPGKSTKPGAAPTEHKALVSHNGSLINVGSL LQRAEQQDSGRLYLENKIHTLELKLEESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQELRRRLTPLQLEIQR -------------------------------------------------------------- >30280_30280_3_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000351936_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=830AA_BP=799 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGE SLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSE NSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENE YGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEV LYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVH KLTKRIPLRRQVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKP KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS FGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGI -------------------------------------------------------------- >30280_30280_4_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000356226_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=715AA_BP=684 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEGAPYWTNTEKMEKRLHAVPA ANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAG LPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGIS FHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVSAESSSSMNSNTP LVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF -------------------------------------------------------------- >30280_30280_5_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000357555_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=744AA_BP=712 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEDAISSGDDEDDTDGAEDFVS ENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVEN EYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIE VLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAV HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVF -------------------------------------------------------------- >30280_30280_6_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000358487_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=832AA_BP=801 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGE SLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSE NSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENE YGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVNTTDKEIEV LYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVH KLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKD KPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFT -------------------------------------------------------------- >30280_30280_7_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000360144_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=744AA_BP=713 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEDAISSGDDEDDTDGAEDFVS ENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVEN EYGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVL ALFNVTEADAGEYICKVSNYIGQANQSAWLTVLPKQQAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPA VHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGID KDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRV -------------------------------------------------------------- >30280_30280_8_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000369056_CCAR2_chr8_22464120_ENST00000308511_length(amino acids)=1641AA_BP=768 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGE YLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCP AGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVV GGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVLALFNVTEADAGEYICKVSNYIGQANQSAWLTVLPK QQAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITT RLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGIVTSLHDYFGVVDEEVFFQLSVVKGRLPQLGE KVLVKAAYNPGQAVPWNAVKVQTLSNQPLLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSHTLHLSHLNRFP ARGPHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDFLELQRRYRSLLVPSDFLSVHLSWLSAFPLSQP FSLHHPSRIQVSSEKEAAPDAGAEPITADSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLGRKEEEAVLVGG EWSPSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQTVVVYLPDVWTIMPTLEEWEALCQQKAAEAAP PTQEAQGETEPTEQAPDALEQAADTSRRNAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKERISFEVMVLAE LFLEMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKDEAQNEGPATESEAPLKEDGLLPKPLSSGGEEE EKPRGEASEDLCEMALDPELLLLRDDGEEEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVFFDANWCGYLHR RDLERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNLDLLPPPGKSTKPGAAPTEHKALVSHNGSLINV GSLLQRAEQQDSGRLYLENKIHTLELKLEESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQELRRRLTPLQLE -------------------------------------------------------------- >30280_30280_9_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000369056_CCAR2_chr8_22464120_ENST00000389279_length(amino acids)=1641AA_BP=768 MVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGESLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGE YLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSENSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCP AGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAGLPANASTVV GGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVLALFNVTEADAGEYICKVSNYIGQANQSAWLTVLPK QQAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITT RLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGIVTSLHDYFGVVDEEVFFQLSVVKGRLPQLGE KVLVKAAYNPGQAVPWNAVKVQTLSNQPLLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSHTLHLSHLNRFP ARGPHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDFLELQRRYRSLLVPSDFLSVHLSWLSAFPLSQP FSLHHPSRIQVSSEKEAAPDAGAEPITADSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLGRKEEEAVLVGG EWSPSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQTVVVYLPDVWTIMPTLEEWEALCQQKAAEAAP PTQEAQGETEPTEQAPDALEQAADTSRRNAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKERISFEVMVLAE LFLEMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKDEAQNEGPATESEAPLKEDGLLPKPLSSGGEEE EKPRGEASEDLCEMALDPELLLLRDDGEEEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVFFDANWCGYLHR RDLERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNLDLLPPPGKSTKPGAAPTEHKALVSHNGSLINV GSLLQRAEQQDSGRLYLENKIHTLELKLEESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQELRRRLTPLQLE -------------------------------------------------------------- >30280_30280_10_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000369059_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=718AA_BP=687 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEGAPYWTNTEKMEKRLHAVPA ANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENEYGSINHTYHLDVVERSPHRPILQAG LPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVLALFNVTEADAGEYICKVSNYIGQANQ SAWLTVLPKQQAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSMNS NTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE -------------------------------------------------------------- >30280_30280_11_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000369060_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=717AA_BP=685 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGE SLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSE NSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENE YGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKVSAESSSSMNSNT PLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL -------------------------------------------------------------- >30280_30280_12_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000369061_CCAR2_chr8_22464120_ENST00000308511_length(amino acids)=1562AA_BP=689 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGE SLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSE NSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENE YGSINHTYHLDVVAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSM NSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGIVTSLHDYFGVVDEEVFFQLS VVKGRLPQLGEKVLVKAAYNPGQAVPWNAVKVQTLSNQPLLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSH TLHLSHLNRFPARGPHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDFLELQRRYRSLLVPSDFLSVHL SWLSAFPLSQPFSLHHPSRIQVSSEKEAAPDAGAEPITADSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLG RKEEEAVLVGGEWSPSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQTVVVYLPDVWTIMPTLEEWEA LCQQKAAEAAPPTQEAQGETEPTEQAPDALEQAADTSRRNAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKE RISFEVMVLAELFLEMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKDEAQNEGPATESEAPLKEDGLL PKPLSSGGEEEEKPRGEASEDLCEMALDPELLLLRDDGEEEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVF FDANWCGYLHRRDLERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNLDLLPPPGKSTKPGAAPTEHKA LVSHNGSLINVGSLLQRAEQQDSGRLYLENKIHTLELKLEESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQE -------------------------------------------------------------- >30280_30280_13_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000369061_CCAR2_chr8_22464120_ENST00000389279_length(amino acids)=1562AA_BP=689 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGE SLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSE NSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENE YGSINHTYHLDVVAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAVHKLTKRIPLRRQVTVSAESSSSM NSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVFTGIVTSLHDYFGVVDEEVFFQLS VVKGRLPQLGEKVLVKAAYNPGQAVPWNAVKVQTLSNQPLLKSPAPPLLHVAALGQKQGILGAQPQLIFQPHRIPPLFPQKPLSLFQTSH TLHLSHLNRFPARGPHGRLDQGRSDDYDSKKRKQRAGGEPWGAKKPRHDLPPYRVHLTPYTVDSPICDFLELQRRYRSLLVPSDFLSVHL SWLSAFPLSQPFSLHHPSRIQVSSEKEAAPDAGAEPITADSDPAYSSKVLLLSSPGLEELYRCCMLFVDDMAEPRETPEHPLKQIKFLLG RKEEEAVLVGGEWSPSLDGLDPQADPQVLVRTAIRCAQAQTGIDLSGCTKWWRFAEFQYLQPGPPRRLQTVVVYLPDVWTIMPTLEEWEA LCQQKAAEAAPPTQEAQGETEPTEQAPDALEQAADTSRRNAETPEATTQQETDTDLPEAPPPPLEPAVIARPGCVNLSLHGIVEDRRPKE RISFEVMVLAELFLEMLQRDFGYRVYKMLLSLPEKVVSPPEPEKEEAAKEEATKEEEAIKEEVVKEPKDEAQNEGPATESEAPLKEDGLL PKPLSSGGEEEEKPRGEASEDLCEMALDPELLLLRDDGEEEFAGAKLEDSEVRSVASNQSEMEFSSLQDMPKELDPSAVLPLDCLLAFVF FDANWCGYLHRRDLERILLTLGIRLSAEQAKQLVSRVVTQNICQYRSLQYSRQEGLDGGLPEEVLFGNLDLLPPPGKSTKPGAAPTEHKA LVSHNGSLINVGSLLQRAEQQDSGRLYLENKIHTLELKLEESHNRFSATEVTNKTLAAEMQELRVRLAEAEETARTAERQKSQLQRLLQE -------------------------------------------------------------- >30280_30280_14_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000457416_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=834AA_BP=802 MKALRVVHARRGSVQMGLTSTWRYGRGPGIGTVTMVSWGRFICLVVVTMATLSLARPSFSLVEDTTLEPEEPPTKYQISQPEVYVAAPGE SLEVRCLLKDAAVISWTKDGVHLGPNNRTVLIGEYLQIKGATPRDSGLYACTASRTVDSETWYFMVNVTDAISSGDDEDDTDGAEDFVSE NSNNKRAPYWTNTEKMEKRLHAVPAANTVKFRCPAGGNPMPTMRWLKNGKEFKQEHRIGGYKVRNQHWSLIMESVVPSDKGNYTCVVENE YGSINHTYHLDVVERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKHSGINSSNAEVLA LFNVTEADAGEYICKVSNYIGQANQSAWLTVLPKQQAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPDFSSQPAV HKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDK DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEGGEKQRVF -------------------------------------------------------------- >30280_30280_15_FGFR2-CCAR2_FGFR2_chr10_123243212_ENST00000478859_CCAR2_chr8_22464120_ENST00000521301_length(amino acids)=571AA_BP=539 MCLNKTKQLFGVAKRLPFWRKERSPHRPILQAGLPANASTVVGGDVEFVCKVYSDAQPHIQWIKHVEKNGSKYGPDGLPYLKVLKAAGVN TTDKEIEVLYIRNVTFEDAGEYTCLAGNSIGISFHSAWLTVLPAPGREKEITASPDYLEIAIYCIGVFLIACMVVTVILCRMKNTTKKPD FSSQPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMA EAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEG -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr10:22462355/chr8:123239535) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
FGFR2 | CCAR2 |
FUNCTION: Tyrosine-protein kinase that acts as cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of cell proliferation, differentiation, migration and apoptosis, and in the regulation of embryonic development. Required for normal embryonic patterning, trophoblast function, limb bud development, lung morphogenesis, osteogenesis and skin development. Plays an essential role in the regulation of osteoblast differentiation, proliferation and apoptosis, and is required for normal skeleton development. Promotes cell proliferation in keratinocytes and immature osteoblasts, but promotes apoptosis in differentiated osteoblasts. Phosphorylates PLCG1, FRS2 and PAK4. Ligand binding leads to the activation of several signaling cascades. Activation of PLCG1 leads to the production of the cellular signaling molecules diacylglycerol and inositol 1,4,5-trisphosphate. Phosphorylation of FRS2 triggers recruitment of GRB2, GAB1, PIK3R1 and SOS1, and mediates activation of RAS, MAPK1/ERK2, MAPK3/ERK1 and the MAP kinase signaling pathway, as well as of the AKT1 signaling pathway. FGFR2 signaling is down-regulated by ubiquitination, internalization and degradation. Mutations that lead to constitutive kinase activation or impair normal FGFR2 maturation, internalization and degradation lead to aberrant signaling. Over-expressed FGFR2 promotes activation of STAT1. {ECO:0000269|PubMed:12529371, ECO:0000269|PubMed:15190072, ECO:0000269|PubMed:15629145, ECO:0000269|PubMed:16384934, ECO:0000269|PubMed:16597617, ECO:0000269|PubMed:17311277, ECO:0000269|PubMed:17623664, ECO:0000269|PubMed:18374639, ECO:0000269|PubMed:19103595, ECO:0000269|PubMed:19387476, ECO:0000269|PubMed:19410646, ECO:0000269|PubMed:21596750, ECO:0000269|PubMed:8663044}. | FUNCTION: Core component of the DBIRD complex, a multiprotein complex that acts at the interface between core mRNP particles and RNA polymerase II (RNAPII) and integrates transcript elongation with the regulation of alternative splicing: the DBIRD complex affects local transcript elongation rates and alternative splicing of a large set of exons embedded in (A + T)-rich DNA regions (PubMed:22446626). Inhibits SIRT1 deacetylase activity leading to increasing levels of p53/TP53 acetylation and p53-mediated apoptosis (PubMed:18235501, PubMed:18235502, PubMed:23352644). Inhibits SUV39H1 methyltransferase activity (PubMed:19218236). Mediates ligand-dependent transcriptional activation by nuclear hormone receptors (PubMed:19131338). Plays a critical role in maintaining genomic stability and cellular integrity following UV-induced genotoxic stress (PubMed:23398316). Regulates the circadian expression of the core clock components NR1D1 and ARNTL/BMAL1 (PubMed:23398316). Enhances the transcriptional repressor activity of NR1D1 through stabilization of NR1D1 protein levels by preventing its ubiquitination and subsequent degradation (PubMed:23398316). Represses the ligand-dependent transcriptional activation function of ESR2 (PubMed:20074560). Acts as a regulator of PCK1 expression and gluconeogenesis by a mechanism that involves, at least in part, both NR1D1 and SIRT1 (PubMed:24415752). Negatively regulates the deacetylase activity of HDAC3 and can alter its subcellular localization (PubMed:21030595). Positively regulates the beta-catenin pathway (canonical Wnt signaling pathway) and is required for MCC-mediated repression of the beta-catenin pathway (PubMed:24824780). Represses ligand-dependent transcriptional activation function of NR1H2 and NR1H3 and inhibits the interaction of SIRT1 with NR1H3 (PubMed:25661920). Plays an important role in tumor suppression through p53/TP53 regulation; stabilizes p53/TP53 by affecting its interaction with ubiquitin ligase MDM2 (PubMed:25732823). Represses the transcriptional activator activity of BRCA1 (PubMed:20160719). Inhibits SIRT1 in a CHEK2 and PSEM3-dependent manner and inhibits the activity of CHEK2 in vitro (PubMed:25361978). {ECO:0000269|PubMed:18235501, ECO:0000269|PubMed:18235502, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:19218236, ECO:0000269|PubMed:20074560, ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:22446626, ECO:0000269|PubMed:23352644, ECO:0000269|PubMed:23398316, ECO:0000269|PubMed:24415752, ECO:0000269|PubMed:24824780, ECO:0000269|PubMed:25361978, ECO:0000269|PubMed:25661920, ECO:0000269|PubMed:25732823}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 154_247 | 765.0 | 820.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 256_358 | 765.0 | 820.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 25_125 | 765.0 | 820.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 154_247 | 765.0 | 786.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 256_358 | 765.0 | 786.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 25_125 | 765.0 | 786.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 154_247 | 650.0 | 705.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 256_358 | 650.0 | 705.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 25_125 | 650.0 | 705.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 154_247 | 678.0 | 708.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 256_358 | 678.0 | 708.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 25_125 | 678.0 | 708.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 154_247 | 767.0 | 822.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 256_358 | 767.0 | 822.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 25_125 | 767.0 | 822.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 481_770 | 767.0 | 822.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 154_247 | 679.0 | 681.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 256_358 | 679.0 | 681.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 25_125 | 679.0 | 681.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 154_247 | 768.0 | 770.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 256_358 | 768.0 | 770.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 25_125 | 768.0 | 770.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 481_770 | 768.0 | 770.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 154_247 | 651.0 | 706.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 256_358 | 651.0 | 706.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 25_125 | 651.0 | 706.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 154_247 | 655.0 | 710.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 256_358 | 655.0 | 710.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 25_125 | 655.0 | 710.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 154_247 | 768.0 | 823.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 256_358 | 768.0 | 823.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 25_125 | 768.0 | 823.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 481_770 | 768.0 | 823.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 487_495 | 765.0 | 820.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 565_567 | 765.0 | 820.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 487_495 | 765.0 | 786.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 565_567 | 765.0 | 786.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 487_495 | 650.0 | 705.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 565_567 | 650.0 | 705.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 487_495 | 678.0 | 708.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 565_567 | 678.0 | 708.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 487_495 | 767.0 | 822.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 565_567 | 767.0 | 822.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 487_495 | 679.0 | 681.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 565_567 | 679.0 | 681.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 487_495 | 768.0 | 770.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 565_567 | 768.0 | 770.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 487_495 | 651.0 | 706.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 565_567 | 651.0 | 706.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 487_495 | 655.0 | 710.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 565_567 | 655.0 | 710.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 487_495 | 768.0 | 823.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 565_567 | 768.0 | 823.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 161_178 | 765.0 | 820.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 161_178 | 765.0 | 786.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 161_178 | 650.0 | 705.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 161_178 | 678.0 | 708.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 161_178 | 767.0 | 822.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 161_178 | 679.0 | 681.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 161_178 | 768.0 | 770.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 161_178 | 651.0 | 706.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 161_178 | 655.0 | 710.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 161_178 | 768.0 | 823.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 22_377 | 765.0 | 820.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 22_377 | 765.0 | 786.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 22_377 | 650.0 | 705.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 22_377 | 678.0 | 708.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 22_377 | 767.0 | 822.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 22_377 | 679.0 | 681.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 22_377 | 768.0 | 770.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 22_377 | 651.0 | 706.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 22_377 | 655.0 | 710.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 22_377 | 768.0 | 823.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 378_398 | 765.0 | 820.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 378_398 | 765.0 | 786.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 378_398 | 650.0 | 705.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 378_398 | 678.0 | 708.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 378_398 | 767.0 | 822.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 378_398 | 679.0 | 681.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 378_398 | 768.0 | 770.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 378_398 | 651.0 | 706.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 378_398 | 655.0 | 710.0 | Transmembrane | Helical |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 378_398 | 768.0 | 823.0 | Transmembrane | Helical |
Tgene | CCAR2 | chr10:123243212 | chr8:22464120 | ENST00000308511 | 2 | 21 | 829_909 | 50.0 | 924.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | CCAR2 | chr10:123243212 | chr8:22464120 | ENST00000389279 | 2 | 21 | 829_909 | 50.0 | 924.0 | Coiled coil | Ontology_term=ECO:0000255 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 481_770 | 765.0 | 820.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 481_770 | 765.0 | 786.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 481_770 | 650.0 | 705.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 481_770 | 678.0 | 708.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 154_247 | 0 | 255.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 256_358 | 0 | 255.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 25_125 | 0 | 255.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 481_770 | 0 | 255.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 481_770 | 679.0 | 681.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 481_770 | 651.0 | 706.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 481_770 | 655.0 | 710.0 | Domain | Protein kinase |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 487_495 | 0 | 255.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 565_567 | 0 | 255.0 | Nucleotide binding | ATP |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 161_178 | 0 | 255.0 | Region | Note=Heparin-binding |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000346997 | - | 16 | 17 | 399_821 | 765.0 | 820.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000351936 | - | 17 | 18 | 399_821 | 765.0 | 786.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000356226 | - | 15 | 16 | 399_821 | 650.0 | 705.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000357555 | - | 16 | 17 | 399_821 | 678.0 | 708.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000358487 | - | 17 | 18 | 399_821 | 767.0 | 822.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 22_377 | 0 | 255.0 | Topological domain | Extracellular |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 399_821 | 0 | 255.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000360144 | - | 16 | 17 | 399_821 | 679.0 | 681.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369056 | - | 16 | 17 | 399_821 | 768.0 | 770.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369060 | - | 15 | 16 | 399_821 | 651.0 | 706.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000369061 | - | 14 | 15 | 399_821 | 655.0 | 710.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000457416 | - | 17 | 18 | 399_821 | 768.0 | 823.0 | Topological domain | Cytoplasmic |
Hgene | FGFR2 | chr10:123243212 | chr8:22464120 | ENST00000359354 | - | 1 | 7 | 378_398 | 0 | 255.0 | Transmembrane | Helical |
Top |
Fusion Protein Structures |
PDB and CIF files of the predicted fusion proteins * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
Top |
pLDDT score distribution |
pLDDT score distribution of the predicted wild-type structures of two partner proteins from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
FGFR2_pLDDT.png |
CCAR2_pLDDT.png |
pLDDT score distribution of the predicted fusion protein structures from AlphaFold2 * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
Top |
Ramachandran Plot of Fusion Protein Structure |
Ramachandran plot of the torsional angles - phi (φ)and psi (ψ) - of the residues (amino acids) contained in this fusion protein peptide. |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
FGFR2 | |
CCAR2 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to FGFR2-CCAR2 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to FGFR2-CCAR2 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FGFR2 | C2931196 | Craniofacial dysostosis type 1 | 23 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR2 | C0220658 | Pfeiffer Syndrome | 21 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | FGFR2 | C0001193 | Apert syndrome | 19 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C0795998 | JACKSON-WEISS SYNDROME | 10 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C0175699 | Saethre-Chotzen Syndrome | 8 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | FGFR2 | C1852406 | Cutis Gyrata Syndrome of Beare And Stevenson | 8 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C2936791 | Antley-Bixler Syndrome, Autosomal Dominant | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C1510455 | Acrocephalosyndactylia | 6 | CTD_human;ORPHANET |
Hgene | FGFR2 | C0265269 | Lacrimoauriculodentodigital syndrome | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C0010278 | Craniosynostosis | 4 | CTD_human;GENOMICS_ENGLAND |
Hgene | FGFR2 | C1863389 | Apert-Crouzon Disease | 4 | CTD_human |
Hgene | FGFR2 | C1865070 | SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C0006142 | Malignant neoplasm of breast | 3 | CTD_human;UNIPROT |
Hgene | FGFR2 | C0030044 | Acrocephaly | 3 | CTD_human |
Hgene | FGFR2 | C0036341 | Schizophrenia | 3 | PSYGENET |
Hgene | FGFR2 | C0221356 | Brachycephaly | 3 | CTD_human |
Hgene | FGFR2 | C0265534 | Scaphycephaly | 3 | CTD_human |
Hgene | FGFR2 | C0265535 | Trigonocephaly | 3 | CTD_human |
Hgene | FGFR2 | C0376634 | Craniofacial Abnormalities | 3 | CTD_human |
Hgene | FGFR2 | C0678222 | Breast Carcinoma | 3 | CTD_human |
Hgene | FGFR2 | C1257931 | Mammary Neoplasms, Human | 3 | CTD_human |
Hgene | FGFR2 | C1458155 | Mammary Neoplasms | 3 | CTD_human |
Hgene | FGFR2 | C1833340 | Synostotic Posterior Plagiocephaly | 3 | CTD_human |
Hgene | FGFR2 | C1860819 | Metopic synostosis | 3 | CTD_human |
Hgene | FGFR2 | C2931150 | Synostotic Anterior Plagiocephaly | 3 | CTD_human |
Hgene | FGFR2 | C3281247 | BENT BONE DYSPLASIA SYNDROME | 3 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | FGFR2 | C4551902 | Craniosynostosis, Type 1 | 3 | CTD_human |
Hgene | FGFR2 | C4704874 | Mammary Carcinoma, Human | 3 | CTD_human |
Hgene | FGFR2 | C0008925 | Cleft Palate | 2 | CTD_human |
Hgene | FGFR2 | C0011570 | Mental Depression | 2 | PSYGENET |
Hgene | FGFR2 | C0011581 | Depressive disorder | 2 | PSYGENET |
Hgene | FGFR2 | C0024623 | Malignant neoplasm of stomach | 2 | CGI;CTD_human |
Hgene | FGFR2 | C0038356 | Stomach Neoplasms | 2 | CGI;CTD_human |
Hgene | FGFR2 | C1708349 | Hereditary Diffuse Gastric Cancer | 2 | CTD_human |
Hgene | FGFR2 | C1837218 | Cleft palate, isolated | 2 | CTD_human |
Hgene | FGFR2 | C0000772 | Multiple congenital anomalies | 1 | CTD_human |
Hgene | FGFR2 | C0003090 | Ankylosis | 1 | CTD_human |
Hgene | FGFR2 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
Hgene | FGFR2 | C0008924 | Cleft upper lip | 1 | CTD_human |
Hgene | FGFR2 | C0010273 | Craniofacial Dysostosis | 1 | CTD_human |
Hgene | FGFR2 | C0011757 | Developmental Coordination Disorder | 1 | CTD_human |
Hgene | FGFR2 | C0014170 | Endometrial Neoplasms | 1 | CTD_human |
Hgene | FGFR2 | C0018553 | Hamartoma Syndrome, Multiple | 1 | CTD_human |
Hgene | FGFR2 | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Hgene | FGFR2 | C0023890 | Liver Cirrhosis | 1 | CTD_human |
Hgene | FGFR2 | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | FGFR2 | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Hgene | FGFR2 | C0026613 | Motor Skills Disorders | 1 | CTD_human |
Hgene | FGFR2 | C0033975 | Psychotic Disorders | 1 | PSYGENET |
Hgene | FGFR2 | C0037268 | Skin Abnormalities | 1 | CTD_human |
Hgene | FGFR2 | C0037274 | Dermatologic disorders | 1 | CTD_human |
Hgene | FGFR2 | C0038219 | Status Dysraphicus | 1 | CTD_human |
Hgene | FGFR2 | C0040427 | Tooth Abnormalities | 1 | CTD_human |
Hgene | FGFR2 | C0080178 | Spina Bifida | 1 | CTD_human |
Hgene | FGFR2 | C0152423 | Congenital small ears | 1 | GENOMICS_ENGLAND |
Hgene | FGFR2 | C0206698 | Cholangiocarcinoma | 1 | CTD_human |
Hgene | FGFR2 | C0206762 | Limb Deformities, Congenital | 1 | CTD_human |
Hgene | FGFR2 | C0239946 | Fibrosis, Liver | 1 | CTD_human |
Hgene | FGFR2 | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Hgene | FGFR2 | C0265326 | Bannayan-Riley-Ruvalcaba Syndrome | 1 | CTD_human |
Hgene | FGFR2 | C0266508 | Rachischisis | 1 | CTD_human |
Hgene | FGFR2 | C0345905 | Intrahepatic Cholangiocarcinoma | 1 | CTD_human |
Hgene | FGFR2 | C0349204 | Nonorganic psychosis | 1 | PSYGENET |
Hgene | FGFR2 | C0391826 | Lhermitte-Duclos disease | 1 | CTD_human |
Hgene | FGFR2 | C0476089 | Endometrial Carcinoma | 1 | CGI;CTD_human |
Hgene | FGFR2 | C0524730 | Odontome | 1 | CTD_human |
Hgene | FGFR2 | C0699791 | Stomach Carcinoma | 1 | CGI;GENOMICS_ENGLAND |
Hgene | FGFR2 | C0917816 | Mental deficiency | 1 | CTD_human |
Hgene | FGFR2 | C1450010 | Plagiocephaly, Nonsynostotic | 1 | CTD_human |
Hgene | FGFR2 | C1860042 | Antley-Bixler Syndrome with Disordered Steroidogenesis | 1 | CTD_human |
Hgene | FGFR2 | C1867564 | SCAPHOCEPHALY AND AXENFELD-RIEGER ANOMALY | 1 | GENOMICS_ENGLAND |
Hgene | FGFR2 | C1959582 | PTEN Hamartoma Tumor Syndrome | 1 | CTD_human |
Hgene | FGFR2 | C2350233 | Antley-Bixler Syndrome Phenotype | 1 | CTD_human |
Hgene | FGFR2 | C3267076 | Familial scaphocephaly syndrome | 1 | GENOMICS_ENGLAND |
Hgene | FGFR2 | C3714756 | Intellectual Disability | 1 | CTD_human |
Hgene | FGFR2 | C3805278 | Extrahepatic Cholangiocarcinoma | 1 | CTD_human |